Drug resistance and microarrays

In cancer research, great hopes were held that microarrays would break the code of cancer cells, leading to better detection and more accurate diagnosis and prognosis. Visions blossomed of personalized medicine, better response rates, decreased side effects and drug resistance, and, eventually, higher cancer cure rates. But thousands of microarray papers later, what have we learned, and where are the success stories?

For full article Click Here